Schizophrenia News and Research

Latest Schizophrenia News and Research

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza Pharmaceuticals, Inc. today announced that it has updated and amended its ADASUVE (Staccato loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd. Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America, the Commonwealth of Independent States and other countries in Europe.

19 Jun 2015

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications, today announced that it has entered into an exclusive license agreement with affiliates of Fagron NV for the commercialization of OMS103, Omeros' product for arthroscopic surgery.

16 Jun 2015

Researchers develop hPSC-based system for producing connections between neurons in the brain

Human stem cells can be differentiated to produce other cell types, such as organ cells, skin cells, or brain cells. While organ cells, for example, can function in isolation, brain cells require synapses, or connectors, between cells and between regions of the brain. In a new study published in Restorative Neurology and Neuroscience, researchers report successfully growing multiple brain structures and forming connections between them in vitro, in a single culture vessel, for the first time.

16 Jun 2015

Two fragile X proteins play crucial role in proper development of neurons

Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.

11 Jun 2015

Study highlights the importance of nutrition for maintaining mental health

An international study involving the Faculty of Medicine and Dentistry of the University of Valencia, recently published in 'The Lancet Psychiatry', highlights the importance of nutrition for maintaining mental health. Lecturer of Psychiatry Vicent Balanzá has participated in this study.

10 Jun 2015

People across the world are living longer but spending more time in ill health

People across the world are living longer but spending more time in ill health as rates of nonfatal diseases and injuries - including diabetes and hearing loss - decline more slowly than death rates, according to a new analysis of 301 diseases and injuries in 188 countries.

9 Jun 2015

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.

8 Jun 2015

Researchers discover initiation process of dendritic spines

Researchers from the University of Helsinki, ETH Zürich, Aix-Marseille and the German Mouse Clinic teamed up to investigate the initiation process of dendritic spines. They discovered that protein called MIM bends the plasma membrane to aid the formation of dendritic spines from the surface of the neuronal dendrite.

5 Jun 2015

Scientists make breakthrough in schizophrenia research

An international team of scientists led by Cardiff University researchers has provided the strongest evidence yet of what causes schizophrenia - a condition that affects around 1% of the global population.

4 Jun 2015

Scientists uncover why some people more prone to major depression

Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.

4 Jun 2015

Scientists produce strongest evidence yet of schizophrenia’s causes

3 Jun 2015

Researchers awarded $3.86 million NIH grant to tackle the issue of 'mosaicism' in schizophrenia

Why does schizophrenia happen, and how can we improve treatment for it? These basic questions persist despite years of research on one of the most puzzling, and debilitating, mental illnesses. Now, a University of Michigan Medical School team and their colleagues will take a new approach to addressing these questions by searching for genetic clues in postmortem brain tissues of people with and without schizophrenia.

30 May 2015

SDSU researchers awarded NIH grant to understand how autism plays out across the lifespan

In the public consciousness, autism spectrum disorder only affects children. In truth, ASD is a lifelong condition. But how it affects older adults is a gaping unknown in autism research. Now, a new and significant grant from the National Institutes of Health will help researchers at San Diego State University understand how the disorder plays out across the lifespan.

29 May 2015

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

Some decisions arouse far more anxiety than others. Among the most anxiety-provoking are those that involve options with both positive and negative elements, such choosing to take a higher-paying job in a city far from family and friends, versus choosing to stay put with less pay.

29 May 2015

Electric brain stimulation may improve short-term memory in individuals with schizophrenia

Lightly stimulating the brain with electricity may improve short-term memory in people with schizophrenia, according to a new study by researchers at the Johns Hopkins University School of Medicine.

28 May 2015

LIBD awarded $200,000 grant to improve lives of people with neurodevelopmental disorders

The Lieber Institute for Brain Development announces the award of a $200,000 grant from the Pennington Family Foundation that will support its efforts to improve the lives of individuals with schizophrenia and related neurodevelopmental disorders.

28 May 2015

Hallucinations, delusions more frequent in general population

Hallucinations and delusions in the general population are more common than previously thought. An international study led by The University of Queensland and Harvard Medical School found that hearing voices and seeing things others cannot impacts about five per cent of the general population at some point in their lives.

28 May 2015

Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Scientists have for the first time shown how the disruption of a key gene involved in mental illness impacts on the brain.

24 May 2015

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.

22 May 2015

New study shows that infections can affect cognitive ability

New research shows that infections can impair your cognitive ability measured on an IQ scale. The study is the largest of its kind to date, and it shows a clear correlation between infection levels and impaired cognition.

21 May 2015

Schizophrenia News and Research

Latest Schizophrenia News and Research

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Researchers develop hPSC-based system for producing connections between neurons in the brain

Two fragile X proteins play crucial role in proper development of neurons

Study highlights the importance of nutrition for maintaining mental health

People across the world are living longer but spending more time in ill health

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Researchers discover initiation process of dendritic spines

Scientists make breakthrough in schizophrenia research

Scientists uncover why some people more prone to major depression

Scientists produce strongest evidence yet of schizophrenia’s causes

Researchers awarded $3.86 million NIH grant to tackle the issue of 'mosaicism' in schizophrenia

SDSU researchers awarded NIH grant to understand how autism plays out across the lifespan

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

Electric brain stimulation may improve short-term memory in individuals with schizophrenia

LIBD awarded $200,000 grant to improve lives of people with neurodevelopmental disorders

Hallucinations, delusions more frequent in general population

Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

New study shows that infections can affect cognitive ability

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Schizophrenia News and Research

Latest Schizophrenia News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in